Streetbeat News

Analyst Ratings

NOV

Morgan Stanley analyst Elizabeth Porter has maintained an Overweight rating on NOV (NYSE:NOV) and raised the price target from $24 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:30 pm

WHD

Barclays has upgraded Cactus Inc. from Equal-Weight to Overweight, leading to a rise in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:30 pm

OLLI

Goldman Sachs has upgraded Ollie's Bargain Outlet's stock from Neutral to Buy and raised its price target from $75 to $83. This has resulted in Ollie's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:29 pm

BAC

In a recent CNBC interview, Bank of America CEO Brian Moynihan stated that he expects loan growth to pick up.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:28 pm

MAXN

Morgan Stanley analyst David Nierengarten has maintained an Equal-Weight rating on Maxeon Solar Technologies (NASDAQ:MAXN) and lowered the price target from $22 to $14.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:28 pm

MPC

Morgan Stanley analyst Connor Lynagh maintains an Overweight rating on Marathon Petroleum (NYSE:MPC) and raises the price target from $150 to $160.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:26 pm

AAPL

MSFT

NFLX

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses trade strategies for SPY, QQQ, AAPL, MSFT, NFLX, TSLA, and NVDA. The memo provides price levels for each stock, which are determined by a proprietary formula that takes into account price, volume, and options flow. The memo recommends monitoring these stocks closely and being prepared to leverage potential breakouts or reversals.

Portfolio Pulse from RIPS

October 17, 2023 | 2:26 pm

LBRT

Morgan Stanley analyst Connor Lynagh has maintained an Equal-Weight rating on Liberty Energy (NYSE:LBRT) and raised the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:25 pm

AKYA

Akoya Biosciences (NASDAQ:AKYA) and The University of Queensland's Frazer Institute have published a study in GEN Biotechnology that used ultrahigh-plex spatial phenotyping to map the spatial proteome of head and neck squamous cell carcinoma (HNSCC). The study identified a high degree of intra- and inter-tumoral heterogeneity intrinsic to head and neck cancers. The analysis was conducted using Akoya's PhenoCycler-Fusion system, which is the fastest spatial biology solution available.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:24 pm

IBM

Morgan Stanley analyst Erik Woodring has maintained an Equal-Weight rating on IBM (NYSE:IBM) but lowered the price target from $135 to $130.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 2:24 pm